MENTOR, Ohio -- STERIS Corporation today announced that Les C. Vinney, president and CEO since 2000, will step down from those roles and as a member of the board of directors by June 1, 2007. After appointment of a successor, Vinney will continue to support the company as special advisor until his retirement in 2009. STERIS announced this mutually agreed transition process to allow a smooth transfer of Vinney's responsibilities and will begin an immediate search for a new president and CEO. This transition is consistent with Vinney's desire to eventually have more time to pursue other goals and interests at this stage of his career, and the company's development and direction.
John P. Wareham, chairman of the STERIS board of directors, noted, "Under Les' leadership, many organizational and operational improvements have been made and new businesses and markets have been opened, which have positioned the company to take advantage of the many opportunities that exist for STERIS. We are very appreciative of Les' many contributions at STERIS and his continued willingness to support the company's objectives, and we wish him every future success and happiness."
The board has formed a search committee to implement the search process for a successor. Additionally, a transition committee appointed by the board and led by Wareham will work with Vinney during the transition process to facilitate a smooth transfer of responsibilities. Wareham further commented, "We expect our succession plan process will support STERIS's continuing efforts to build on its remarkable past and achieve even greater successes in the future."
Vinney commented, "It has been my distinct pleasure to serve STERIS in various leadership roles during a period that has positioned the company as a $1.2 billion global leader in the rapidly developing areas of infection control, decontamination and health sciences. I am proud of the many accomplishments achieved and the shareholder value created by my 5,000 STERIS colleagues over the past seven years. The company is now well positioned for a new leader to take it to new heights."
Vinney joined STERIS in August 1999 as senior vice president and chief financial officer, and was elected senior vice president of finance and operations in October 1999. He was named president and CEO in March 2000, and president and CEO in July
2000. Prior to joining STERIS, Vinney served as senior vice president and chief financial officer of the BF Goodrich Company.
Source: STERIS
Â
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.